3-148886112-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001870.4(CPA3):c.1001G>A(p.Gly334Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000105 in 1,613,186 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001870.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPA3 | NM_001870.4 | c.1001G>A | p.Gly334Asp | missense_variant | 10/11 | ENST00000296046.4 | NP_001861.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPA3 | ENST00000296046.4 | c.1001G>A | p.Gly334Asp | missense_variant | 10/11 | 1 | NM_001870.4 | ENSP00000296046 | P1 | |
ENST00000488190.1 | n.163-16023C>T | intron_variant, non_coding_transcript_variant | 1 | |||||||
CPA3 | ENST00000477926.1 | n.478G>A | non_coding_transcript_exon_variant | 4/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152084Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000558 AC: 14AN: 250916Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135644
GnomAD4 exome AF: 0.000108 AC: 158AN: 1461102Hom.: 0 Cov.: 29 AF XY: 0.000106 AC XY: 77AN XY: 726826
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152084Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74282
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 18, 2023 | The c.1001G>A (p.G334D) alteration is located in exon 10 (coding exon 10) of the CPA3 gene. This alteration results from a G to A substitution at nucleotide position 1001, causing the glycine (G) at amino acid position 334 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at